Weisi Liu

1.1k total citations
33 papers, 651 citations indexed

About

Weisi Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Weisi Liu has authored 33 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Weisi Liu's work include Renal cell carcinoma treatment (13 papers), Renal and related cancers (7 papers) and Galectins and Cancer Biology (7 papers). Weisi Liu is often cited by papers focused on Renal cell carcinoma treatment (13 papers), Renal and related cancers (7 papers) and Galectins and Cancer Biology (7 papers). Weisi Liu collaborates with scholars based in China, United States and Israel. Weisi Liu's co-authors include Jiejie Xu, Weijuan Zhang, Haiou Liu, Yidong Liu, Jianxin Gu, Qiang Fu, Deng Pan, Le Xu, Qian Wu and Yidong Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Weisi Liu

33 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weisi Liu China 16 405 192 166 165 97 33 651
Xiuqing Dong China 16 379 0.9× 312 1.6× 176 1.1× 221 1.3× 143 1.5× 36 779
Alexander J. Cole Australia 14 357 0.9× 132 0.7× 184 1.1× 164 1.0× 44 0.5× 31 775
Gaia Giannone Italy 14 262 0.6× 169 0.9× 156 0.9× 341 2.1× 109 1.1× 32 740
Christophe Willekens France 18 375 0.9× 143 0.7× 162 1.0× 186 1.1× 63 0.6× 50 946
Leonel Maldonado United States 14 359 0.9× 126 0.7× 180 1.1× 168 1.0× 104 1.1× 30 674
Khalil Choucair United States 12 337 0.8× 124 0.6× 108 0.7× 234 1.4× 178 1.8× 36 693
Evelien W. Duiker Netherlands 14 332 0.8× 114 0.6× 291 1.8× 345 2.1× 48 0.5× 26 750
Gloria Marquina Spain 10 294 0.7× 89 0.5× 120 0.7× 127 0.8× 95 1.0× 32 499
Rong‐Miao Zhou China 19 459 1.1× 231 1.2× 147 0.9× 294 1.8× 74 0.8× 61 868
Jitian Li China 16 336 0.8× 155 0.8× 155 0.9× 142 0.9× 86 0.9× 29 615

Countries citing papers authored by Weisi Liu

Since Specialization
Citations

This map shows the geographic impact of Weisi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weisi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weisi Liu more than expected).

Fields of papers citing papers by Weisi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weisi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weisi Liu. The network helps show where Weisi Liu may publish in the future.

Co-authorship network of co-authors of Weisi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Weisi Liu. A scholar is included among the top collaborators of Weisi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weisi Liu. Weisi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Weisi, Francesca Khani, LaMont Barlow, et al.. (2022). The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer. Cancer Research. 83(4). 506–520. 20 indexed citations
2.
Ma, Xiaowei, Jianyun Lu, & Weisi Liu. (2022). Knowledge of Emerging and Reemerging Infectious Diseases in the Public of Guangzhou, Southern China. Frontiers in Public Health. 10. 718592–718592. 1 indexed citations
3.
Liu, Weisi, et al.. (2021). Travel-related infection in Guangzhou, China,2009–2019. Travel Medicine and Infectious Disease. 43. 102106–102106. 4 indexed citations
4.
Ma, Xiaowei, Jianyun Lu, & Weisi Liu. (2021). Influencing Factors on Health Information to Improve Public Health Literacy in the Official WeChat Account of Guangzhou CDC. Frontiers in Public Health. 9. 657082–657082. 16 indexed citations
5.
Liu, Weisi, et al.. (2018). Cross-Sectional Study on Acceptability of the Media Channels About Ebola Virus Disease in Guangzhou, China. Vector-Borne and Zoonotic Diseases. 18(9). 475–478. 1 indexed citations
6.
Liu, Yidong, Qiang Fu, Zewei Wang, et al.. (2017). Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 35(6). 349–355. 22 indexed citations
7.
Liu, Weisi, Yidong Liu, Haiou Liu, et al.. (2015). Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinoma. Journal of Biological Chemistry. 290(47). 28489–28501. 20 indexed citations
8.
An, Huimin, Yu Zhu, Huyang Xie, et al.. (2015). Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. Tumor Biology. 37(4). 4523–4529. 9 indexed citations
9.
Liu, Haiou, Weisi Liu, Zheng Liu, et al.. (2015). Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection. Tumor Biology. 36(7). 5039–5049. 17 indexed citations
10.
Fu, Hangcheng, Yidong Liu, Le Xu, et al.. (2015). Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma. Tumor Biology. 36(8). 5791–5799. 32 indexed citations
11.
Liu, Haiou, Qian Wu, Yidong Liu, et al.. (2015). Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma. Japanese Journal of Clinical Oncology. 45(9). 844–853. 11 indexed citations
12.
Liu, Haiou, Yidong Liu, Weisi Liu, Weijuan Zhang, & Jiejie Xu. (2015). EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma. Nature Communications. 6(1). 8494–8494. 102 indexed citations
13.
Liu, Haiou, Qian Wu, Weisi Liu, et al.. (2015). ST6Gal-I Predicts Postoperative Clinical Outcome for Patients with Localized Clear-cell Renal Cell Carcinoma. Asian Pacific Journal of Cancer Prevention. 15(23). 10217–10223. 5 indexed citations
14.
Liu, Weisi, Haiou Liu, Yidong Liu, et al.. (2014). Prognostic Significance of p21-activated Kinase 6 Expression in Patients with Clear Cell Renal Cell Carcinoma. Annals of Surgical Oncology. 21(S4). 575–583. 15 indexed citations
15.
16.
17.
Wang, Shanshan, Yu Zhu, Hongyong He, et al.. (2013). Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2. Cancer Science. 104(6). 750–759. 23 indexed citations
18.
Liu, Jian, Hongliang Liu, Weizhen Zhang, et al.. (2013). N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation. Glycobiology. 23(9). 1097–1109. 32 indexed citations
19.
Chen, Lin, Haiou Liu, Jing Liu, et al.. (2013). Klotho Endows Hepatoma Cells with Resistance to Anoikis via VEGFR2/PAK1 Activation in Hepatocellular Carcinoma. PLoS ONE. 8(3). e58413–e58413. 38 indexed citations
20.
Liu, Weisi. (2003). Establishment and evaluation on emergency surveillance and notification system of SARS in Guangzhou. China Public Health. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiuqing Dong Breakdown of academic impact, for papers by Alexander J. Cole Breakdown of academic impact, for papers by Gaia Giannone Breakdown of academic impact, for papers by Christophe Willekens Breakdown of academic impact, for papers by Leonel Maldonado Breakdown of academic impact, for papers by Khalil Choucair Breakdown of academic impact, for papers by Evelien W. Duiker Breakdown of academic impact, for papers by Gloria Marquina Breakdown of academic impact, for papers by Rong‐Miao Zhou Breakdown of academic impact, for papers by Jitian Li
Rankless by CCL
2026